Editor's Note
Among the actions announced April 15 by the Food & Drug Administration (FDA) in response to the COVID-19 pandemic are:
Stress and burnout are more than workforce concerns; they are…
The centralization of medical device processing to one facility is…
With the explosion of GLP-1–based therapies for type 2 diabetes…